These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7037354)

  • 1. Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.
    Brogden RN; Carmine A; Heel RC; Morley PA; Speight TM; Avery GS
    Drugs; 1981 Nov; 22(5):337-62. PubMed ID: 7037354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor.
    Smith BR; LeFrock JL
    Drug Intell Clin Pharm; 1985 Jun; 19(6):415-20. PubMed ID: 3891282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
    Van den Ende J; Gricius ME; De Klerk HC; Neiteler BF; Forder AA; Venter L; Hallett AF; Koornhof HJ; Robinson R; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):5A-8A. PubMed ID: 6979805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amoxycillin: A review of its antibacterial and pharmacokinietic properties and therapeutic use.
    Brogeden RN; Speight TM; Avery GS
    Drugs; 1975; 9(2):88-140. PubMed ID: 1126306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.
    Ball AP; Geddes AM; Davey PG; Farrell ID; Brookes GR
    Lancet; 1980 Mar; 1(8169):620-3. PubMed ID: 6102627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The history and background of Augmentin.
    Rolinson GN
    S Afr Med J; 1982 Jul; 62(5 Spec No):3A-4A. PubMed ID: 6979804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clavulanate-potentiated amoxycillin: activity in vitro and bioavailability in the dog.
    Bywater RJ; Palmer GH; Buswell JF; Stanton A
    Vet Rec; 1985 Jan; 116(2):33-6. PubMed ID: 3871985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentin (amoxycillin and clavulanic acid) in the treatment of urinary tract infections.
    Leigh A
    Scott Med J; 1982; 27 Spec No.():S28-34. PubMed ID: 6984778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.
    Matsuura M; Nakazawa H; Hashimoto T; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jun; 17(6):908-11. PubMed ID: 6967713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary tract infections in children. Status in a pediatric hospital and sensitivity of bacterial strains to amoxycillin-clavulanic acid combination].
    Cochat N; Barbe G; Boutin-Tranchant ME; Cochat P
    Pediatrie; 1987; 42(4):309-14. PubMed ID: 3671031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
    Thornley PE; Aitken JM; Nichol GM; Slevin NJ
    Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992.
    Neu HC; Wilson AP; Grüneberg RN
    J Chemother; 1993 Apr; 5(2):67-93. PubMed ID: 8515298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of an amoxycillin/clavulanic acid combination in the treatment of common bacterial infections. A general practitioner trial.
    Levenstein JH
    S Afr Med J; 1982 Jul; 62(5 Spec No):16A-20A. PubMed ID: 7046104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced effects of amoxycillin/clavulanic acid compared with amoxycillin and clavulanic acid alone on the susceptibility to immunodefenses of a penicillin-resistant strain of Streptococcus pneumoniae.
    Cuffini AM; Tullio V; Ianni Palarchio A; Bonino A; Paizis G; Carlone NA
    Drugs Exp Clin Res; 1998; 24(4):173-84. PubMed ID: 10051963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections.
    Goldstein FW; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1979 Nov; 5(6):705-9. PubMed ID: 395156
    [No Abstract]   [Full Text] [Related]  

  • 19. Amoxycillin and clavulanic acid in the treatment of urinary infection.
    Al Roomi LG; Sutton AM; Cockburn F; McAllister TA
    Arch Dis Child; 1984 Mar; 59(3):256-9. PubMed ID: 6712275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of respiratory tract infections in children: a study of a combination of amoxycillin and clavulanic acid.
    Fiocchi A; Zuccotti G; Bellù R; Marangione P; Riva E; Giovannini M
    J Int Med Res; 1990; 18(4):326-33. PubMed ID: 2227080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.